January 10, 2020 Recruitment satisfactory for foreign-educated health providers
(HealthDay)—Foreign-educated health professionals (FEHPs) in the United States are overall satisfied with their recruitment experience, according to a study published in the January issue of the American Journal of Nursing .
Franklin A. Shaffer, Ed.D., R.N., president and chief executive officer of CGFNS International in Philadelphia, and colleagues conducted a survey of FEHPs, recruited from those who used VisaScreen services between 2015 and 2017, to assess their recruitment experiences. The survey was conducted by CGFNS International and its Alliance for Ethical International Recruitment Practices division between April and May 2018, and there were 1,017 respondents. A smaller subset of foreign-educated nurses was interviewed.
The researchers found that 69 percent of FEHPs had a positive recruitment experience. However, there are issues such as high breach fees, inadequate orientation, and misalignment of expectations regarding work environment and location. Specifically, 80 percent of FEHPs knew their wages before signing, but 9 percent had to pay a recruiter fee. Further, 47 percent had breach fees of at least $15,000 in their contracts. Some FEHPs who later tried to leave their job reported being threatened with prosecution for "immigration fraud" or having their visas revoked.
"Given that FEHP migration to the United States is likely to continue its upward trajectory, better strategies to implement market-wide practices that ensure the safe, orderly, and ethical recruitment of FEHPs are needed," the authors write. Explore further More information: Abstract/Full Text Copyright © 2020 HealthDay . All rights reserved. Citation : Recruitment satisfactory for foreign-educated health providers (2020, January 10) retrieved 10 January 2020 from https://medicalxpress.com/news/2020-01-satisfactory-foreign-educated-health.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
Also in Industry News
How to decide whether or not to start treatment for prostate cancer?
Analysis of the SARS-CoV-2 proteome via visual tools
$65m investment increases British Patient Capital’s exposure to life sciences and health technology